We are live on ! Find out more
ACIU icon

AC Immune
ACIU

15 hedge funds and large institutions have $110M invested in AC Immune in 2017 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 2 increasing their positions, 3 reducing their positions, and 6 closing their positions.

New
Increased
Maintained
Reduced
Closed

21% more capital invested

Capital invested by funds: $90.4M → $110M (+$19.4M)

0.94% less ownership

Funds ownership: 18.06% → 17.12% (-0.94%)

12% less funds holding

Funds holding: 17 → 15 (-2)

33% less first-time investments, than exits

New positions opened: 4 | Existing positions closed: 6

33% less repeat investments, than reductions

Existing positions increased: 2 | Existing positions reduced: 3

Holders
15
Holders Change
-2
Holders Change %
-11.76%
% of All Funds
0.37%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
4
Increased
2
Reduced
3
Closed
6
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
+$6.42M
2
TCM
Tekla Capital Management
Massachusetts
+$350K
3
Geode Capital Management
Geode Capital Management
Massachusetts
+$145K
4
Janney Montgomery Scott
Janney Montgomery Scott
Pennsylvania
+$103K
5
Wells Fargo
Wells Fargo
California
+$85.3K

Top Sellers

Rank Fund Capital Flow
1
JG
Jefferies Group
New York
-$6.41M
2
HIM
Hillhouse Investment Management
Cayman Islands
-$4.84M
3
Citadel Advisors
Citadel Advisors
Florida
-$540K
4
LBC
Lawrence B. Cohen
-$177K
5
Renaissance Technologies
Renaissance Technologies
New York
-$177K

ACIU Hedge Fund Activity: Q3 2017 in Review

15 of the 4,022 institutional investors tracked by Wall St. Rank reported a position in AC Immune (ACIU) for Q3 2017, worth a combined $110M — up 21% from $90.4M a quarter earlier.

Sellers outnumbered buyers: 6 funds closed out of ACIU and 4 opened new positions — a net loss of 2 holders — while 3 trimmed existing stakes and 2 added.

The largest buyer was Fidelity Investments, adding an estimated $6.42M. The largest seller was Jefferies Group, exiting entirely with an estimated $6.41M sold.

  • 15 institutional investors held AC Immune (ACIU) as of Q3 2017, down from 17 in Q2 2017.
  • Funds reported $110M of AC Immune stock for Q3 2017, up 21% quarter-over-quarter.
  • 4 funds opened new AC Immune positions in Q3 2017 and 6 closed out, a net change of -2 holders.
  • The largest AC Immune buyer in Q3 2017 was Fidelity Investments, an estimated $6.42M added.
  • The largest AC Immune seller in Q3 2017 was Jefferies Group, an estimated $6.41M sold.

Based on aggregated 13F filings for Q3 2017.